0001209191-19-030613.txt : 20190516 0001209191-19-030613.hdr.sgml : 20190516 20190516184228 ACCESSION NUMBER: 0001209191-19-030613 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190515 FILED AS OF DATE: 20190516 DATE AS OF CHANGE: 20190516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHAFER CAROL CENTRAL INDEX KEY: 0001272181 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 19833725 MAIL ADDRESS: STREET 1: 42 WHITE STREET, FOURTH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-15 0 0001175505 FIVE PRIME THERAPEUTICS INC FPRX 0001272181 SCHAFER CAROL 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (right to buy) 9.17 2019-05-15 4 A 0 25000 0.00 A 2029-05-14 Common Stock 25000 25000 D The shares underlying this option vest at a rate of one-third per year on each anniversary of May 15, 2019, subject to the reporting person's continued service to Five Prime Therapeutics, Inc. through each such date. /s/ Francis Sarena, Attorney-in-fact 2019-05-16